CD-P-PH/PHO - Classification of Medicines as Regards their Supply
The Council of Europe has been long concerned with the supply conditions for medicines for human use and the harmonisation of national legislation in this field.
The availability of medicines with or without a medical prescription has implications on patient safety, accessibility of medicines to patients and responsible management of health care expenditure.
The decision on prescription status and related supply conditions is a core competency of national health authorities. The conditions of the supply of medicines vary considerably in Council of Europe member States, due to the fact that the provisions are differently interpreted and implemented by the member States, and that important additional classification criteria are not harmonised.
In continuing with the programme of activities carried out under the aegis of the former Partial Agreement in the Social and Public Health ﬁeld, the Committee of Experts on the Classiﬁcation of Medicines as Regards their Supply (CD-P-PH/PHO) reviews the national legal supply status of medicinal products for human use and issues recommendations on the classiﬁcation of medicines and their supply conditions to health authorities of the Council of Europe member States parties to the Ph. Eur. Convention.
- View the 2022-2025 Terms of Reference of the Committee of Experts CD-P-PH/PHO
Resolution CM/Res(2018)1 on the classification of medicines as regards their supply (superseding Resolution ResAP(2007)1 on the classification of medicines as regards their supply) (Adopted by the Committee of Ministers on 10 April 2018)
If you wish to know the classification of a medicine in a particular country or the CD-P-PH/PHO’s recommendation on the prescription status and related supply conditions of a medicine, you can do so via the